Hosted on MSN3mon
Novo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback